DelveInsight’s “Surgical Site Infections – Market Insight, Epidemiology, And Market Forecast – 2034″ report offers an in-depth understanding of the Surgical Site Infections, historical and forecasted epidemiology as well as the Surgical Site Infections market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
Some of the key facts of the Surgical Site Infections Market Report:
• According to DelveInsight, the market for Surgical Site Infections in the 7MM is expected to witness notable growth during the study period from 2020 to 2034.
• According to findings, cigarette smoking has a negative impact on wound healing in orthopedic surgery, with an increase in the incidence of surgical site infection of 7%.
• Research indicates that surgical site infections occur in 2% to 4% of all patients undergoing inpatient surgical procedures.
• The overall incidence of surgical site infections was around 10% in the early 2000s, gradually decreasing to 7% by 2007 and further dropping to 5% by 2020.
• In March 2025, PolyPid Ltd. announced the successful completion of enrollment in the SHIELD II Phase 3 trial for D-PLEX100, aimed at preventing surgical site infections in patients undergoing abdominal colorectal surgery.
• In August 2024, Guard Medical Inc. announced FDA 510(k) clearance for larger sizes of its NPseal Negative Pressure Wound Therapy (NPWT) dressing, now available for surgical wounds up to 25cm. NPseal is a user-friendly, affordable dressing with an integrated pump that quickly establishes and maintains negative pressure.
• Emerging therapies in the Surgical Site Infections Treatment Market focus on innovations like PolyPid’s D-PLEX100 for localized antibiotic delivery and Destiny Pharma’s XF-73 antimicrobial peptides, aiming to reduce infections and fight antibiotic resistance.
• Leading companies in the Surgical Site Infections market include Destiny Pharma, PolyPid, Menarini Group Pharma, Botanix Pharma, Dr. Reddy’s Laboratories Ltd., Zurex Pharma, and others.
• The rising number of radiation therapy patients and advancements in therapeutic options continue to drive the demand for effective Surgical Site Infections treatments.
To know in detail about the Surgical Site Infections market outlook, drug uptake, treatment scenario, and epidemiology trends, click here: Surgical Site Infections Market Forecast
Surgical Site Infections Overview
A surgical site infection (SSI) is an infection that develops at or near the incision site following a surgical procedure, potentially affecting different tissue layers. Common symptoms include redness, swelling, pain, fever, and the discharge of cloudy or purulent fluid. SSIs typically emerge within 30 days post-surgery and are categorized by the Centers for Disease Control and Prevention (CDC) into three types:
Superficial Incisional SSI: Affects the skin and subcutaneous tissue at the incision site.
Deep Incisional SSI: Involves deeper layers such as muscles and surrounding tissues.
Organ or Space SSI: Occurs in internal organs or spaces manipulated during surgery.
Diagnosis relies on clinical evaluation, wound cultures to identify infectious agents, and imaging techniques if deeper infections are suspected. Prompt identification and treatment are essential to managing SSIs and preventing complications.
Get a Free sample for the Surgical Site Infections Market Report:https://www.delveinsight.com/report-store/surgical-site-infections-ssi-market
Surgical Site Infections Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Surgical Site Infections Epidemiology Segmentation:
The Surgical Site Infections epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by:
• Total Incident Cases of Surgical Site Infections
• Type-specific Cases of Surgical Site Infections,
• Organ-specific Cases of Surgical Site Infections
• Treated Cases of Surgical Site Infections
Download the report to understand which factors are driving Surgical Site Infections epidemiology trends @ Surgical Site Infections Epidemiology Forecast
Surgical Site Infections Drugs Uptake, and Pipeline Development Activities
The drug uptake section focuses on the rate of uptake of the potential drugs recently launched in the Surgical Site Infections market or expected to be launched during the study period. The analysis covers the Surgical Site Infections market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Surgical Site Infections Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Surgical Site Infections Market Strengths
• Increased awareness among healthcare professionals and patients, along with the implementation of stringent infection control protocols, has significantly contributed to reducing surgical site infections (SSIs). Advancements in antiseptic techniques, sterilization methods, and infection surveillance programs further strengthen the market.
• The development and adoption of novel antimicrobial-coated sutures, wound dressings, and advanced therapies such as negative pressure wound therapy (NPWT) have enhanced infection prevention and management, driving market growth.
Surgical Site Infections Market Weaknesses
• The implementation of advanced infection prevention strategies, including antimicrobial dressings, surveillance systems, and prophylactic antibiotic administration, can be costly, posing a challenge for healthcare facilities with limited budgets, especially in low- and middle-income countries.
• The growing concern over antimicrobial resistance (AMR) limits the effectiveness of traditional antibiotic therapies for SSIs, making treatment more challenging and increasing the need for novel antimicrobial strategies, which may take longer to develop and commercialize.
Scope of the Surgical Site Infections Market Report
• Study Period: 2020–2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Surgical Site Infections Therapies: D-PLEX100, XF-73 Nasal gel, and others.
• Key Surgical Site Infections Companies: Destiny Pharma, PolyPid, Menarini Group Pharma, Botanix Pharma, Dr. Reddy’s Laboratories Ltd., Zurex Pharma, and others.
• Surgical Site Infections Therapeutic Assessment: Surgical Site Infections currently marketed and Surgical Site Infections emerging therapies
• Surgical Site Infections Market Dynamics: Surgical Site Infections market drivers and Surgical Site Infections market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
• Surgical Site Infections Unmet Needs, KOL’s views, Analyst’s views, Surgical Site Infections Market Access and Reimbursement
To learn more about the key players and advancements in the Surgical Site Infections Treatment Landscape, visit the Surgical Site Infections Market Analysis Report
Table of Contents
1. Surgical Site Infections Market Report Introduction
2. Executive Summary for Surgical Site Infections
3. SWOT analysis of Surgical Site Infections
4. Surgical Site Infections Patient Share (%) Overview at a Glance
5. Surgical Site Infections Market Overview at a Glance
6. Surgical Site Infections Disease Background and Overview
7. Surgical Site Infections Epidemiology and Patient Population
8. Country-Specific Patient Population of Surgical Site Infections
9. Surgical Site Infections Current Treatment and Medical Practices
10. Surgical Site Infections Unmet Needs
11. Surgical Site Infections Emerging Therapies
12. Surgical Site Infections Market Outlook
13. Country-Wise Surgical Site Infections Market Analysis (2020–2034)
14. Surgical Site Infections Market Access and Reimbursement of Therapies
15. Surgical Site Infections Market Drivers
16. Surgical Site Infections Market Barriers
17. Surgical Site Infections Appendix
18. Surgical Site Infections Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
Media ContactCompany Name: DelveInsightContact Person: Jatin VimalEmail: Send EmailPhone: +14699457679Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/
